KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Accumulated Expenses (2016 - 2018)

Idexx Laboratories has reported Other Accumulated Expenses over the past 9 years, most recently at $65.8 million for Q1 2018.

  • Quarterly results put Other Accumulated Expenses at $65.8 million for Q1 2018, up 18.53% from a year ago — trailing twelve months through Mar 2018 was $65.8 million (up 18.53% YoY), and the annual figure for FY2017 was $64.4 million, down 10.49%.
  • Other Accumulated Expenses for Q1 2018 was $65.8 million at Idexx Laboratories, up from $64.4 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for IDXX hit a ceiling of $72.0 million in Q4 2016 and a floor of $44.6 million in Q1 2014.
  • Median Other Accumulated Expenses over the past 5 years was $60.2 million (2015), compared with a mean of $58.9 million.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 38.03% in 2015 and later decreased 11.34% in 2017.
  • Idexx Laboratories' Other Accumulated Expenses stood at $55.7 million in 2014, then grew by 17.99% to $65.7 million in 2015, then rose by 9.62% to $72.0 million in 2016, then decreased by 10.49% to $64.4 million in 2017, then rose by 2.18% to $65.8 million in 2018.
  • The last three reported values for Other Accumulated Expenses were $65.8 million (Q1 2018), $64.4 million (Q4 2017), and $60.8 million (Q3 2017) per Business Quant data.